Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma	Not yet recruiting	Phase 2	2026-03-09		NCT07457775

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Second Affiliated Hospital, Zhejiang University, School of Medicine	561

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
2nd Affiliated Hospital, School of Medicine	Hangzhou	China	8

Clinical trials